Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06676306 · ClinicalTrials.gov registry record
Patient and Caregiver Priorities in Neuro-oncology Care
A clinical trial of Malignant Central Nervous System Neoplasm and Metastatic Malignant Neoplasm in the Central Nervous System, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT06676306 is a study of Malignant Central Nervous System Neoplasm and Metastatic Malignant Neoplasm in the Central Nervous System that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 1,777-participant average among 3 other Malignant Central Nervous System Neoplasm trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06676306, a study of Malignant Central Nervous System Neoplasm and Metastatic Malignant Neoplasm in the Central Nervous System, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to identify patient and caregiver burdens regarding their experience with diagnosis and treatment of CNS tumors. These results will help doctors find areas where patients and caregivers may need more support.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-04-24 |
| Est. Completion | 2026-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06676306
The ClinicalTrials.gov registry entry for NCT06676306 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,777-participant average among 3 other Malignant Central Nervous System Neoplasm trials with a reported enrollment target (95% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Malignant Central Nervous System Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06676306 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06676306 about?
NCT06676306 is a clinical study titled "Patient and Caregiver Priorities in Neuro-oncology Care". This study is being done to identify patient and caregiver burdens regarding their experience with diagnosis and treatment of CNS tumors. These results will help doctors find areas where patients and caregivers may need more support.
What is the current status of trial NCT06676306?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2024-04-24. Estimated completion is 2026-04-30.
What conditions does trial NCT06676306 study?
This clinical trial studies the following conditions: Malignant Central Nervous System Neoplasm, Metastatic Malignant Neoplasm in the Central Nervous System.
What interventions are being tested in trial NCT06676306?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06676306?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06676306 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Central Nervous System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
RECRUITING
-
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
RECRUITING
-
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
COMPLETED · Phase 1
Explore more on PlainTrial
Malignant Central Nervous System Neoplasm
All registered trials for this condition
Metastatic Malignant Neoplasm in the Central Nervous System
All registered trials for this condition
Minnesota
All trials with a study site in Minnesota
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.